Literature DB >> 15014653

Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders.

Prakash S. Masand1.   

Abstract

Behavioral disturbances and psychosis are common features of neurodegenerative disorders and may be drug induced, intrinsic to the underlying pathology, or both. These disturbances, including psychotic and mood symptoms, apathy, aggression and other behavioral symptoms, and superimposed delirium, cause a great amount of disability to the patient and stress on the caregiver. Conventional neuroleptics have been shown to be effective in the treatment of these symptoms, but unacceptable side effects may occur. However, the novel antipsychotics, with their lower risk of inducing extrapyramidal symptoms, have shown promise in the treatment of behavioral disturbances and psychosis associated with neurodegenerative disorders.

Entities:  

Year:  2000        PMID: 15014653      PMCID: PMC181113          DOI: 10.4088/pcc.v02n0302

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  58 in total

1.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Authors:  I R Katz; D V Jeste; J E Mintzer; C Clyde; J Napolitano; M Brecher
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

2.  Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

Authors:  J P van Vugt; S Siesling; M Vergeer; E A van der Velde; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 3.  Psychiatric presentations of medical illness.

Authors:  C M Marsh
Journal:  Psychiatr Clin North Am       Date:  1997-03

Review 4.  Psychoses: diagnosis and treatment in the elderly.

Authors:  D V Jeste; F S McClure
Journal:  New Dir Ment Health Serv       Date:  1997

5.  Olanzapine can worsen parkinsonism.

Authors:  F J Jiménez-Jiménez; A Tallón-Barranco; M Ortí-Pareja; M Zurdo; J Porta; J A Molina
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

6.  [Psychotic symptoms as the initial manifestation of multiple sclerosis?].

Authors:  H Becker
Journal:  Psychiatr Prax       Date:  1997-03

7.  Use of risperidone in delirium: case reports.

Authors:  A Sipahimalani; P S Masand
Journal:  Ann Clin Psychiatry       Date:  1997-06       Impact factor: 1.567

Review 8.  Clozapine for the treatment of psychosis in Parkinson's disease: a review.

Authors:  P Auzou; C Ozsancak; D Hannequin; N Moore; P Augustin
Journal:  Acta Neurol Scand       Date:  1996-11       Impact factor: 3.209

9.  Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.

Authors:  E Scholz; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 10.  Depressive disorders in the medically ill. An overview.

Authors:  E H Cassem
Journal:  Psychosomatics       Date:  1995 Mar-Apr       Impact factor: 2.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.